The benefits and cost-savings of a new point-of-care test for chlamydia and gonorrhoea
We developed an understanding of how sexual health clinics in England could use a rapid point of care test for two common sexually transmitted infections. We defined the current patient care pathways and found that the pathways could be streamlined and costs of care reduced by using point-of-care tests. The economic model developed by Aquarius Population Health showed that the test could deliver £10 million in cost savings, and give far more effective management of chlamydia and gonorrhoea at a population level.
Cost effectiveness of screening for Chlamydia trachomatis in Ireland
Costs and cost-effectiveness of different strategies for chlamydia screening and partner notification
What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia?
